People Briefs

John Kenneth Hulm, chief scientist emeritus at the Westinghouse Electric Corp., has been appointed to the U.S.-Japan Joint High Level Advisory Panel by Allan Bromley, the president's assistant for science and technology. The advisory panel is composed of 20 distinguished U.S. and Japanese scientists and engineers from industry and academia. Formed in 1988, the panel provides advice to both governments on their science and technology relationship. Hulm, a physicist who is internationally recogni

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

John Kenneth Hulm, chief scientist emeritus at the Westinghouse Electric Corp., has been appointed to the U.S.-Japan Joint High Level Advisory Panel by Allan Bromley, the president's assistant for science and technology. The advisory panel is composed of 20 distinguished U.S. and Japanese scientists and engineers from industry and academia. Formed in 1988, the panel provides advice to both governments on their science and technology relationship. Hulm, a physicist who is internationally recognized as an authority on superconductivity, retired as chief scientist from the Westinghouse Science & Technology Center two years ago. As chief scientist, he was responsible for the planning, development, and funding of the company's scientific programs. A native of England, Hulm earned his Ph.D. in physics in 1949. He was research fellow and professor at the University of Chicago before coming to Westinghouse in 1954.

Philip Emeagwali, a graduate student in the civil engineering department and the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies